Description Panorama Capital doesn't just take the long view. The company, formerly the high-tech and biotech investment arm of J.P. Morgan Partners (JPMP), was spun off in 2006 and focuses its investment lens on life sciences and technology sector firms in the US and Canada. It oversees an approximately $800 million investment portfolio that includes interests in more than 30 companies, such as outsourcing firm Axiom Legal, W-Fi systems developer BelAir Networks, and drug discovery company Renovo. Panorama Capital was formed in 2005 when JPMP divided its investment activities into asset specialties and buyouts and venture capital.